Mr. Thiroloix will be responsible for leading and directing commercial activities in Europe, focusing on orthopedic and sports medicine products. He has experience with sales and marketing with various companies in Europe and most recently served as executive vice president of corporate development at global biopharmaceutical company Ipsen.
Related Articles on Orthopedic and Spine Devices:
More Insurance Companies Now Reimburse for TranS1’s AxiaLIF
Zimmer Signs Distribution Agreement for Benvenue Medical’s Vertebral Compression Fracture Treatment System
Stryker’s Net Earnings Decline, Acquisitions Save Sales Growth
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
